Main Responsibilities of the National Medical Products Administration
(1) To supervise the safety of drugs (including traditional Chinese medicines (TCMs) and ethno-medicines, the same below), medical devices and cosmetics; to draw up regulatory policy plans, organize the drafting of laws and regulations, formulate normative documents, and supervise the implementation thereof; to research and formulate regulatory and supportive policies that encourage new technologies and new products for drugs, medical devices and cosmetics.
(2) To undertake standards management for drugs, medical devices and cosmetics; to organize the formulation and publication of the Chinese Pharmacopoeia and other drug and medical device standards, organize the drafting of cosmetic standards, organize the formulation of the classification management system, and supervise the implementation thereof; to participate in formulating the National Essential Medicine List, and assist in the implementation of the national essential medicine system.
(3) To regulate the registration of drugs, medical devices and cosmetics; to develop the registration system, conduct strict review and approval for marketing, improve measures to facilitate the review and approval process, and organize the implementation thereof.
(4) To undertake quality management for drugs, medical devices and cosmetics; to develop Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), and supervise the implementation thereof; to develop Good Manufacturing Practices (GMP) and supervise the implementation thereof in line with NMPA’s responsibilities; to develop good practices on the distribution and use of medical products and guide the implementation thereof.
(5) To undertake post-market risk management for drugs, medical devices and cosmetics; to organize the monitoring, evaluation, and handling of adverse drug reactions, medical device adverse events, and cosmetic adverse reactions; to undertake emergency response management for drugs, medical devices and cosmetics in accordance with law.
(6) To undertake management of qualifications for licensed pharmacists; to formulate regulations of qualifications for licensed pharmacists, and guide and supervise the registration of licensed pharmacists.
(7) To organize and guide the supervision and inspection of drugs, medical devices and cosmetics; to develop the inspection system, investigate and punish illegal activities during the registration process for drugs, medical devices and cosmetics in accordance with law, and organize and guide the investigation and punishment of illegal activities during the manufacturing process in line with NMPA’s responsibilities.
(8) To engage in international exchange and cooperation in the regulation of drugs, medical devices and cosmetics, and participate in developing relevant international regulatory rules and standards.
(9) To guide the work of drug regulatory departments of all provinces, autonomous regions, and municipalities directly under the Central Government.
(10) To complete other tasks assigned by the CPC Central Committee and the State Council.
下一篇:原卫生部《进口非特殊用途化妆品备案凭证》 »
相关文章:
- [ABOUT]Cooperation Process of Imported Cosmetics Registration
- [ABOUT]Documents Preparation
- [ABOUT]Procedure
- [ABOUT]EVENTS
- [ABOUT]Commitments
- [ABOUT]Cooperation cases
- [ABOUT]Contact Us
- [ABOUT]Services
- [ABOUT]BeijingTianjianhuacheng International Investment Co.,Ltd
- [ABOUT]How to choose a professional agency?
相关推荐:
- [申报资讯]浙江省药品化妆品审评中心关于接受业务咨询的公告
- [审批动态]2022年05月23日化妆品决定书邮寄详情单
- [政策法规]保健食品稳定性试验指导原则(征求意见稿)
- [申报资讯]国家药监局关于发布《化妆品中新康唑等8种组分的测定》化妆品补充检验方法的公告(2022年第77号)
- [政策法规]关于破壁灵芝孢子粉定性有关问题的复函(不作为普通食品管理)
- [审批动态]2021年12月23日化妆品批准证明文件邮寄详情单
- [费用预算]进口/国产保健食品备案注册申报时,国家市监局收取审评费吗?
- [申报资讯]江苏|进口普通化妆品6.30前未提交年度报告限期改正
- [审批动态]2023年8月31日保健食品批件(决定书)待领取信息-1
- [申报资讯]国家药监局综合司关于化妆品质量安全负责人有关问题的复函
-
86-010-84828041/42
400-6167-168
zhuceabc@zhuceabc.com
咨询微信:
13601366497(化妆品类)
1801335159(特殊食品类)







